Jaguar Health Inc. (NASDAQ: JAGX)
$4.12
-0.0550 ( -1.32% ) 440.2K
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Market Data
Open
$4.12
Previous close
$4.17
Volume
440.2K
Market cap
$20.09M
Day range
$4.05 - $4.27
52 week range
$3.07 - $41.76
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 16, 2024 |
8-k | 8K-related | 15 | Jun 26, 2024 |
8-k | 8K-related | 15 | Jun 21, 2024 |
8-k | 8K-related | 13 | Jun 10, 2024 |
ars | Annual reports | 1 | May 28, 2024 |
8-k | 8K-related | 19 | May 23, 2024 |
def | Proxies and info statements | 8 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |